Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma

被引:2
|
作者
Peller, S [1 ]
Halperin, R
Schneider, D
Kopilova, Y
Rotter, V
机构
[1] Assaf Harofeh Med Ctr, Dept Hematol, IL-70300 Zerifin, Israel
[2] Assaf Harofeh Med Ctr, Dept Gynecol, IL-70300 Zerifin, Israel
[3] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel
关键词
p53 tumor suppressor gene; p53; polymorphism; ovarian carcinoma; endometrial; carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 gene is frequently mutated in various human tumors. Polymorphism is an additional genetic alteration observed in exons and introns of the p53 gene of normal tissues and tumors. Distributions of alleles of three common polymorphisms of the p53 gene; a 16 bp duplication in intron 3, codon 72 of exon 4 and a sequence in intron 6, were studied in peripheral white blood cells (WBC) of patients with ovarian or endometrial carcinomas. The analysis was performed by PCR and direct sequencing. The 100% linkage observed between the most common haplotypes of each polymorphism in healthy subjects was lower in the patients. A significant difference was observed between frequencies of genotype and haplotype combinations in patients with ovarian carcinoma and endometrial carcinoma. The incidence of heterozygosity was increased in ovarian carcinoma and decreased in endometrial carcinoma. Our results suggest that the p53 gene may be involved in susceptibility and predisposition to various cancers not only by mutations but also by preferential presentation of polymorphic alleles.
引用
收藏
页码:193 / 197
页数:5
相关论文
共 50 条
  • [31] HPV and p53 expression in epithelial ovarian carcinoma
    Kuscu, E
    Ozdemir, BH
    Erkanli, S
    Haberal, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2005, 26 (06) : 642 - 645
  • [32] p53 and gene therapy for hepatocellular carcinoma
    Habib, NA
    Mitry, RR
    Sadri, R
    GENE THERAPY OF CANCER, 1998, 451 : 499 - 504
  • [33] Hepatocellular carcinoma and p53 gene therapy
    Fricker, J
    MOLECULAR MEDICINE TODAY, 1996, 2 (09): : 361 - 361
  • [34] p53 mutation in epithelial ovarian carcinoma and borderline ovarian tumor
    Lee, JH
    Kang, YS
    Park, SY
    Kim, BG
    Lee, ED
    Lee, KH
    Park, KB
    Kavanagh, JJ
    Wharton, JT
    CANCER GENETICS AND CYTOGENETICS, 1995, 85 (01) : 43 - 50
  • [35] ALTERATIONS OF THE P53 GENE IN NASOPHARYNGEAL CARCINOMA
    EFFERT, P
    MCCOY, R
    ABDELHAMID, M
    FLYNN, K
    ZHANG, Q
    BUSSON, P
    TURSZ, T
    LIU, E
    RAABTRAUB, N
    JOURNAL OF VIROLOGY, 1992, 66 (06) : 3768 - 3775
  • [36] p53 gene mutation in thyroid carcinoma
    Ho, YS
    Tseng, SC
    Chin, TY
    Hsieh, LL
    Lin, JD
    CANCER LETTERS, 1996, 103 (01) : 57 - 63
  • [37] p53 gene mutation in colorectal carcinoma
    Roa, JC
    Roa, I
    Melo, A
    Araya, JC
    Villaseca, MA
    Flores, M
    Schneider, B
    REVISTA MEDICA DE CHILE, 2000, 128 (09) : 996 - 1004
  • [38] Significance of p53 expression in background endometrium in endometrial carcinoma
    Thuy Thi Nguyen
    Toru Hachisuga
    Rie Urabe
    Tomoko Kurita
    Seiji Kagami
    Toshinori Kawagoe
    Shohei Shimajiri
    Kazuki Nabeshima
    Virchows Archiv, 2015, 466 : 695 - 702
  • [39] BCL-2 and p53 expression in endometrial carcinoma
    Erkanli, S
    Eren, F
    Pekin, S
    Bagis, T
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (01) : 97 - 103
  • [40] Significance of p53 expression in background endometrium in endometrial carcinoma
    Thuy Thi Nguyen
    Hachisuga, Toru
    Urabe, Rie
    Kurita, Tomoko
    Kagami, Seiji
    Kawagoe, Toshinori
    Shimajiri, Shohei
    Nabeshima, Kazuki
    VIRCHOWS ARCHIV, 2015, 466 (06) : 695 - 702